NA

ID: ALA4580738

Chembl Id: CHEMBL4580738

PubChem CID: 141650139

Max Phase: Preclinical

Molecular Formula: C55H89N2O14PS

Molecular Weight: 1065.36

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CO[C@@H]1C[C@H](C[C@@H](C)[C@@H]2CC[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C(\C)C(N3CCCS3(=O)=O)C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)CC[C@H]1OP(C)(C)=O

Standard InChI:  InChI=1S/C55H89N2O14PS/c1-35-18-13-12-14-19-37(3)45(57-28-17-29-73(57,65)66)34-43-24-22-41(7)55(63,70-43)52(60)53(61)56-27-16-15-20-44(56)54(62)69-46(38(4)32-42-23-26-47(48(33-42)67-8)71-72(10,11)64)25-21-36(2)31-40(6)50(59)51(68-9)49(58)39(5)30-35/h12-14,18-19,31,35-36,38-39,41-48,50-51,59,63H,15-17,20-30,32-34H2,1-11H3/b14-12+,18-13+,37-19+,40-31+/t35-,36+,38-,39-,41-,42+,43+,44+,45?,46+,47-,48-,50-,51+,55-/m1/s1

Standard InChI Key:  OGXIPDVLRGUPQZ-XZCRSXPXSA-N

Alternative Forms

  1. Parent:

    ALA4580738

    ---

Associated Targets(non-human)

Mtor Serine/threonine-protein kinase mTOR (114 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 1065.36Molecular Weight (Monoisotopic): 1064.5772AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Abdel-Magid AF..  (2019)  Rapalogs Potential as Practical Alternatives to Rapamycin.,  10  (6): [PMID:31223435] [10.1021/acsmedchemlett.9b00215]

Source